Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1453-1460
Open Access | Times Cited: 549

Showing 1-25 of 549 citing articles:

Adipose tissue and insulin resistance in obese
Bulbul Ahmed, Rifat Sultana, Michael W. Greene
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111315-111315
Open Access | Times Cited: 569
Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 482
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 403
Metabolic-associated fatty liver disease and lipoprotein metabolism
Jöerg Heeren, Ludger Scheja
Molecular Metabolism (2021) Vol. 50, pp. 101238-101238
Open Access | Times Cited: 403
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
P. Barton Duell, Francine K. Welty, Michael Miller, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 6
Open Access | Times Cited: 383
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Audrey Deprince, Joel T. Haas, Bart Staels
Molecular Metabolism (2020) Vol. 42, pp. 101092-101092
Open Access | Times Cited: 367
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics
Pauline Morigny, Jérémie Boucher, Peter Arner, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 5, pp. 276-295
Open Access | Times Cited: 353
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 337
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Mihoko Yoshino, Jun Yoshino, Brandon D. Kayser, et al.
Science (2021) Vol. 372, Iss. 6547, pp. 1224-1229
Open Access | Times Cited: 292
Role of Insulin Resistance in MAFLD
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4156-4156
Open Access | Times Cited: 274
Lipogenesis inhibitors: therapeutic opportunities and challenges
Battsetseg Batchuluun, Stephen L. Pinkosky, Gregory R. Steinberg
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 283-305
Open Access | Times Cited: 265
Exercise and metabolic health: beyond skeletal muscle
John P. Thyfault, Audrey Bergouignan
Diabetologia (2020) Vol. 63, Iss. 8, pp. 1464-1474
Open Access | Times Cited: 258
NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 250
Lipid droplet biogenesis and functions in health and disease
Armella Zadoorian, Ximing Du, Hongyuan Yang
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 443-459
Open Access | Times Cited: 246
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 239
A guide to understanding endoplasmic reticulum stress in metabolic disorders
Imke L. Lemmer, Nienke Willemsen, Nazia Hilal, et al.
Molecular Metabolism (2021) Vol. 47, pp. 101169-101169
Open Access | Times Cited: 226
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
Mihoko Yoshino, Brandon D. Kayser, Jun Yoshino, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 8, pp. 721-732
Open Access | Times Cited: 209
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Hannele Yki‐Järvinen, Panu K. Luukkonen, Leanne Hodson, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 770-786
Open Access | Times Cited: 193
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 193
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, et al.
Clinical Science (2022) Vol. 136, Iss. 18, pp. 1347-1366
Open Access | Times Cited: 174
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
Douglas G. Mashek
Molecular Metabolism (2020) Vol. 50, pp. 101115-101115
Open Access | Times Cited: 164
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus
Jing Yong, James D. Johnson, Peter Arvan, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 455-467
Open Access | Times Cited: 158
Page 1 - Next Page

Scroll to top